0001209191-21-056425.txt : 20210916 0001209191-21-056425.hdr.sgml : 20210916 20210916170114 ACCESSION NUMBER: 0001209191-21-056425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210915 FILED AS OF DATE: 20210916 DATE AS OF CHANGE: 20210916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Akinsanya Karen CENTRAL INDEX KEY: 0001797672 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 211258522 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1540 BROADWAY STREET 2: 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 1540 BROADWAY STREET 2: 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-15 0 0001490978 Schrodinger, Inc. SDGR 0001797672 Akinsanya Karen C/O SCHRODINGER, INC., 1540 BROADWAY, 24TH FLOOR NEW YORK NY 10036 0 1 0 0 See Remarks Common Stock 2021-09-15 4 M 0 1394 4.34 A 1394 D Common Stock 2021-09-15 4 S 0 1394 61.13 D 0 D Stock Option (right to buy) 4.34 2021-09-15 4 M 0 1394 0.00 D 2028-11-29 Common Stock 1394 44591 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021. This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022. EVP, Chief Biomedical Scientist, Head of Discovery R&D /s/ Donald Shum, as attorney-in-fact for Karen Akinsanya 2021-09-16